- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 92,200 | 02.07.24 08:03:10 | -0,070 | -0,08% | 92,040 | 92,270 | 92,200 | 92,270 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 975,200 | 01.07.24 18:30:06 | -1,400 | -0,14% | 981,600 | 987,600 | 995,000 | 975,200 |
